Literature DB >> 12065907

Mucosal immunity: its role in defense and allergy.

Helena Tlaskalová-Hogenová1, Ludmila Tucková, Rája Lodinová-Zádniková, Renata Stepánková, Bozena Cukrowska, David P Funda, Ilja Striz, Hana Kozáková, Ilja Trebichavský, Dan Sokol, Zuzana Reháková, Jirí Sinkora, Petra Fundová, Dana Horáková, Lenka Jelínková, Daniel Sánchez.   

Abstract

The interface between the organism and the outside world, which is the site of exchange of nutrients, export of products and waste components, must be selectively permeable and at the same time, it must constitute a barrier equipped with local defense mechanisms against environmental threats (e.g. invading pathogens). The boundaries with the environment (mucosal and skin surfaces) are therefore covered with special epithelial layers which support this barrier function. The immune system, associated with mucosal surfaces covering the largest area of the body (200-300 m(2)), evolved mechanisms discriminating between harmless antigens and commensal microorganisms and dangerous pathogens. The innate mucosal immune system, represented by epithelial and other mucosal cells and their products, is able to recognize the conserved pathogenic patterns on microbes by pattern recognition receptors such as Toll-like receptors, CD14 and others. As documented in experimental gnotobiotic models, highly protective colonization of mucosal surfaces by commensals has an important stimulatory effect on postnatal development of immune responses, metabolic processes (e.g. nutrition) and other host activities; these local and systemic immune responses are later replaced by inhibition, i.e. by induction of mucosal (oral) tolerance. Characteristic features of mucosal immunity distinguishing it from systemic immunity are: strongly developed mechanisms of innate defense, the existence of characteristic populations of unique types of lymphocytes, colonization of the mucosal and exocrine glands by cells originating from the mucosal organized tissues ('common mucosal system') and preferential induction of inhibition of the responses to nondangerous antigens (mucosal tolerance). Many chronic diseases, including allergy, may occur as a result of genetically based or environmentally induced changes in mechanisms regulating mucosal immunity and tolerance; this leads to impaired mucosal barrier function, disturbed exclusion and increased penetration of microbial, food or airborne antigens into the circulation and consequently to exaggerated and generalized immune responses to mucosally occurring antigens, allergens, superantigens and mitogens. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12065907     DOI: 10.1159/000059397

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  23 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Colostrum of healthy mothers contains broad spectrum of secretory IgA autoantibodies.

Authors:  Jaroslava Pribylova; Klara Krausova; Ingrid Kocourkova; Pavel Rossmann; Klara Klimesova; Miloslav Kverka; Helena Tlaskalova-Hogenova
Journal:  J Clin Immunol       Date:  2012-07-10       Impact factor: 8.317

3.  Impact of heat-inactivated Lactobacillus casei and Lactobacillus paracasei strains on cytokine responses in whole blood cell cultures of children with atopic dermatitis.

Authors:  B Cukrowska; I Rosiak; E Klewicka; I Motyl; M Schwarzer; Z Libudzisz; H Kozakova
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

4.  Effect of Gui Zhi decoction on enteric mucosal immune in mice with collagen-induced arthritis.

Authors:  Gui-Qin Zhou; Ning Zhao; Hao Zhang; Hong-Wei Jia; Wan-Dong Zhang; Lin-Hua Zhao; Cheng Lu; Ying-Hui He; Ai-Ping Lu
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

5.  Oral mucosal endotoxin tolerance induction in chronic periodontitis.

Authors:  Manoj Muthukuru; Ravi Jotwani; Christopher W Cutler
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 6.  Immune-directed support of rich microbial communities in the gut has ancient roots.

Authors:  Larry J Dishaw; John P Cannon; Gary W Litman; William Parker
Journal:  Dev Comp Immunol       Date:  2014-06-28       Impact factor: 3.636

Review 7.  Epithelial cells in ocular allergy.

Authors:  Murat Irkeç; Banu Bozkurt
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

Review 8.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

9.  Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis.

Authors:  Lenka Frolova; Pavel Drastich; Pavel Rossmann; Klara Klimesova; Helena Tlaskalova-Hogenova
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

10.  Spontaneous cytokine production in children according to biological characteristics and environmental exposures.

Authors:  Camila Alexandrina Figueiredo; Neuza Maria Alcântara-Neves; Rafael Veiga; Leila D Amorim; Vitor Dattoli; Lívia Ribeiro Mendonça; Samuel Junqueira; Bernd Genser; Mariese Santos; Lain Carlos Pontes de Carvalho; Philip J Cooper; Laura Rodrigues; Maurício L Barreto
Journal:  Environ Health Perspect       Date:  2009-01-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.